OncoArendi Therapeutics SA(DE:1B1)
€1.18-0.02 (-3.90%)
DE:1B1
OncoArendi Therapeutics SA Revenue
€1.18
At close:-0.02 (-3.90%)
OncoArendi Therapeutics SA (1B1) Revenue
0 Followers
OncoArendi Therapeutics SA Revenue
OncoArendi Therapeutics SA had a revenue of 0.00 in the quarter ending Sep 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 168.28K, Increased 0.00%. In the fiscal year ending Dec 31, 2025, OncoArendi Therapeutics SA had annual revenue of 0.00 with -100.00% growth.
- Revenue (ttm)
- 168.28K
- Revenue Growth
- ―
- P/S Ratio
- ―
- Revenue/Employee
- EUR 0
- Employees
- 102
- Market Cap
- EUR 30.76M
Revenue Chart
OncoArendi Therapeutics SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 0.00 | -2.92M | -100.00% |
| Dec 31, 2024 | 2.92M | 2.92M | 2919000.00% |
| Mar 31, 2024 | 100.00 | -7.51M | -100.00% |
| Dec 31, 2022 | 7.51M | 7.51M | 1878262.25% |
| Dec 31, 2021 | 400.00 | -122.94M | -100.00% |
| Dec 31, 2020 | 122.94M | 122.93M | 4379536.62% |
| Dec 31, 2019 | 2.81K | -193.00 | -6.43% |
| Dec 31, 2018 | 3.00K | -3.00K | -50.00% |
| Dec 31, 2017 | 6.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.